US 7910692
Immunogenic peptides and methods of use
granted A61KA61K2239/59A61K38/08
Quick answer
US patent 7910692 (Immunogenic peptides and methods of use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 39
- CPC classes
- A61K, A61K2239/59, A61K38/08, A61K39/0011, A61K40/11